Clinical Trials Directory

Trials / Unknown

UnknownNCT05197686

Early-initiated High Flow Oxygen Therapy vs Conventional Oxygen Therapy Among Patients With ARDS in the Course of SARS-CoV2 Pneumonia.

Early-initiated High Flow Oxygen Therapy vs Conventional Oxygen Therapy Among Patients With ARDS in the Course of SARS-CoV2 Pneumonia: Prognosis and Impact on the Respiratory and Cardiovascular Systems.

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Pomeranian Medical University Szczecin · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is to compare two methods of oxygen therapy in patients with acute respiratory distress syndrome in the course of SARS-CoV2 pneumonia. The initial method of oxygen supply during coronavirus pneumonia is conventional oxygen therapy using a face mask or nasal cannula. However, there have been reports in the literature that early initiation of high-flow oxygen therapy with a nasal cannula is associated with better prognosis. The study we perform is intended to provide reliable evidence for confirmation this hypothesis.

Conditions

Interventions

TypeNameDescription
DEVICEOxygen theraphy with high flow nasal cannuleOxygen theraphy with high flow nasal cannule
DEVICEOxygen theraphy with mask with reservoirOxygen theraphy with mask with reservoir

Timeline

Start date
2022-01-18
Primary completion
2022-06-30
Completion
2022-12-31
First posted
2022-01-19
Last updated
2022-01-19

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT05197686. Inclusion in this directory is not an endorsement.